MIRA
INFORM REPORT
|
Report Date : |
21.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
N K ENGINEERING
COMPANY |
|
|
|
|
Registered Office : |
Plot No. 1808,
Phase III, GIDC Industrial Area, Vatva, Ahmedabad – 382 445, Gujarat |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
1988 |
|
|
|
|
Legal Form : |
Partnership Concern with an Unlimited Liability of the Partners |
|
|
|
|
Line of Business : |
Manufacturer,
Suppliers & Exporter of Pharma Packaging Machinery, Sealing Machine,
Pharmaceutical Machine, Washing, Filling, Sealing, Sticker Labeling Machine
etc. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 40000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well
established concern having satisfactory track. Payments are reported as
experienced, respectable and having satisfactory means of their own. Their
trade relations are fair. Payments are usually correct and as per commitments.
The concern can
be considered normal for business dealings at usual trade terms and
conditions. |
LOCATIONS
|
Registered Office : |
Plot No. 1808,
Phase III, GIDC Industrial Area, Vatva, Ahmedabad – 382 445, Gujarat, India |
|
Tel. No.: |
91-79-25890834/
25891746 |
|
Mobile No.: |
91-9824094078 |
|
Fax No.: |
91-79-25894282/
25890841 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
1200 sq. ft. |
|
Location : |
Leased |
PARTNERS
|
Name : |
Mr. Hitesh Mevada
(Mistry) |
|
Designation : |
Partners |
|
Email: |
|
|
|
|
|
Name : |
Mr. Darshan N.
Mevada |
|
Designation : |
Partners |
|
Mobile No.: |
91-9824094078 |
|
Email: |
|
|
|
|
|
Name : |
Mr. Sunil Pandit |
|
Designation : |
General Manager |
|
Email: |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer,
Suppliers & Exporter of Pharma Packaging Machinery, Sealing Machine, Pharmaceutical
Machine, Washing, Filling, Sealing, Sticker Labeling Machine etc. |
|
|
|
|
Exports : |
|
|
Countries : |
USA, France,
Ireland, Brazil, Egypt, UAE, Malaysia, Singapore, Philippines, Syria,
Bangladesh and Nigeria |
|
|
|
|
Imports : |
|
|
Countries : |
Europe |
|
|
|
|
Terms : |
|
|
Selling : |
L/C, Cash and
Credit (60 days) |
|
|
|
|
Purchasing : |
L/C, Cash and
Credit (30 days) |
GENERAL
INFORMATION
|
Customers : |
Export market and
Local manufacturing Units in India. Ø
Glaxo Ø
Cadila
Pharmaceuticals Ø
Baidyanath Ø
NATCO Ø
Mapra Lab Ø
Alembic
Limited Ø
Zydus Cadila Ø
Torrent Ø
Plethico
Pharmaceuticals Limited Ø
Shreechem
Parma |
|
|
|
|
No. of Employees : |
100 |
|
|
|
|
Bankers : |
Not Available |
|
|
|
|
Facilities : |
Credit Limit: Rs.
5.000 Millions |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Associates: |
Ø
N K Group of
Companies Ø
N K
Industries Ø
N K Pharma
Industries Ø
N K
Engineers (Works) |
|
|
|
|
Membership: |
Ø
Gujarat
Chamber of Commerce & Industry (GCCI) Ø
Engineering
Export Promotion Council (EEPC) |
CAPITAL STRUCTURE
|
Capital Investment : |
|
|
Owned : |
Rs. 10.000
Millions |
|
Borrowed : |
-- |
|
Total : |
Rs. 10.000
Millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
|
Particulars |
|
|
31.03.2006 |
|
Sales Turnover |
|
|
75.000 |
|
|
|
|
|
|
Profit/Loss for the year |
|
|
3.750 |
|
|
|
|
|
|
Export Value |
|
|
30.000 |
|
|
|
|
|
|
Import Value |
|
|
25.000 |
Average Stock maintained:
Rs. 5.000 Millions p.m.
LOCAL AGENCY
FURTHER INFORMATION
Company Profile:
For
the last 30 years N. K. Engineering Company (NK)—headed by its Chairman, Mr. N.
R. Mevada, a well-known personality in the Indian pharma market—has led a blazing
trail in the manufacture of machinery for the pharmaceutical industry that is
growing out of bound.
N K began with a view to blend technological excellence with engineering
skills to customize cost-effective solutions for the specific requirements of
their varied clients.
N K Engineering
Company Manufacturers & exporters of packaging machineries like washing
machine, powder filling machine, liquid filling machine, sealing machine,
labelling machine and special purpose machinery.
Subject are manufacturer of Capping machine, sealing machine, Cap Sealing, Filling machine, Labeling machine, washing machine and packaging machinery solutions for pharmaceuticals, chemicals, cosmetics, pesticides, food-beverages and packaging industry.
Subject is willing to invite parties from USA, UK, England, Europe, Australia, Japan, Netherlands, Kenya, Germany, France, China, Sri Lanka, Bangladesh, Pakistan for Packaging solution for pharmaceuticals, chemicals, cosmetics, pesticides, food-beverages etc.
DETAILS OF
ASSOCIATES:
N K GROUP OF
COMPANIES:
N K Group of companies established in 1988, is engaged in manufacturing and marketing futuristic pharma machinery with utmost detailing and perfection thereby assuring end users a totally hassle-free performance for year of operation thereby assuring end user a totally hassle-free performance for years of operation. Other segment of manufacturing interests includes food & beverage, cosmetics, chemicals and pesticides.
Besides being a leader in domestic pharma segment N K boasts of an impressive track record in exports too. A range of pharma packaging machinery for Injectable Powder, Dry Syrup and Liquid Lines to name a few, are exported to over 12 countries on a regular basis.
N K
INDUSTRIES:
Address: Plot No. 1521, Phase- III, GIDC
Estate, Vatva, Ahmedabad-382 445, Gujarat State, India.
Tel. No.: 91-79-25834979/ 25895909
Email: info@nkcapingmachine.com
Website: www.mkcapingmachine.com
Key Personnel:
Mr. Kirti Mevada
(Partner)
Mobile No.: 91-824072738
N K Industries celebratory
manufacturing excellence in the field of machinery for pharmaceuticals,
chemicals, cosmetics, pesticides, food & beverages and packaging
industries. The company is located at Vatva industries estate in Ahmedabad city
at India.
Company Profile:
|
Business Type |
Manufacturer & Exporter. |
|
Capital in Rupees |
15.Million |
|
Export Percentage |
50% |
|
Primary Competitive Advantages |
A long experience having installation of more than 500 machines all over world. All of their products meet International Standard Quality |
|
Sales Volume |
Rs.8.000 to 90.000Million. |
|
No of Staff |
10 |
|
Year of Establishment |
1985 |
|
No of Production Lines |
5 |
|
Export Markets |
Bangladesh, Malaysia, Nigeria, China, Pakistan,
UAE and Canada |
|
Investment on Manufacturing
Equipment |
Rs.5.000 to 6.000 Million. |
|
OEM Service Provided |
No |
|
Production Type |
Semi-Automatic / Wholly Owned |
|
No of Engineers |
4 |
|
Monthly Production Capacity |
3 to 4 Machines |
|
Memberships |
ISMMA |
|
Product Range |
Machinery for Pharmaceuticals, Chemicals,
Cosmetics, Pesticides, Food-Beverages and Packaging Industry. |
N
K PHARMA INDUSTRIES:
Address: 1814/ B, Phase – III, GIDC Industrial Estate, Vatava, Ahmedabad – 382 445, Gujarat, India.
Tel. No.: 91-79-25890834/25891746
Fax No.: 91-79-25894282
Email: info@pharmaceuticalsmachinery.com
Website: www.pharmaceuticalsmachinery.com
Contact Person:
|
Name : |
Mr. Hitesh Mevada
|
|
Designation : |
Director |
|
Email: |
|
|
|
|
|
Name : |
Mr. Darshan N.
Mevada |
|
Designation : |
Director |
|
Email: |
|
|
|
|
|
Name : |
Mr. Sunil Pandit |
|
Designation : |
General Manager |
|
Email: |
Their Counter Part for Europe & USA
For the last three years N K Pharma Industries - Machinery Div. (NK) - headed by its Chairman, Mr. N.R. Mevada, a well-known personality in the Indian pharma market—has led a blazing trail in the manufacture of machinery for the pharmaceutical industry that is growing out of bound.
N K began with a view to blend technological excellence with engineering skills
to customize cost-effective solutions for the specific requirements of their
varied clients.
The Company
The company’s aim is to align itself with the national concerns of healthcare and leverage the giant leap and growth in the pharmaceutical industry to great advantage for the company and in effect, to the billions who are employed in the health sector.
They expect to continue to succeed in their ambitions by upholding the quality of their products to fulfil their client’s expectations.
The motto, "Real Quality towards Customer Rapport" drives us to great
lengths in demonstrating what builds and sustains an enduring bond with their
clients.
Besides being a leader in domestic pharma segment NK boasts
of an impressive track record in exports too. A range of pharma packaging
machinery for Injectable Powder, Dry Syrup and Liquid Lines to name a few, are
exported to over 12 countries on a regular basis.
N.K's Core Services
The core services of N.K. include manufacturing and monitoring activities of
the Pharmaceutical range of machineries. These services are designed to facilitate
safe, rapid and efficient transaction of goods. increase safety and long-term
reliability of their equipments to prevent the disruption of delivery and
production schedules of their customers.
They have recently launched a new scheme of
providing a specialised service to their customers, engineers and operators:
This service provides product orientation, and user interaction for product
maintenance and optimisations.
They have their own training center for installation & commissioning of
equipment as per the WHO standards.
With NK's enormous experience, they are capable of taking projects for pharma
industry from designing of the plant to the final production as per WHO
standards.
N.K's Human Resourcs
In order to provide a wide range of quality services covering their extensive
product range, they maintain a large work force of well qualified, trained and
experienced people to make sustained client servicing a reality.
N.K.'s R & D Drive
Only last year they have innovated over 12 new models.
Continual product innovation is the main feature of the manufacturing process.
Unique ideas and alternatives are implemented soon after testing to enable us
to update and even overtake their own benchmarks.
They have already started a new journey of TQM (Total Quality Management) in
their Company with the primary objective to offer maximum possible range of
their products by continual research on the next
generation of pharmaceutical machinery.
The New Venture
A successful operation in the pharma market for over 30 years gave enough boost
to NK to venture into Dry Powder Injectable Formulation Plant adhering to
international quality standards and duly certified by WHO GMP with a production
capacity of 2.100 Millions vials per month. This has been commissioned in
accordance with
Lenox Systems:
Address: 14 Edward Road, Bray, Co. Wicklow, Ireland..
Tel. No.: 353 1 202 2222
Fax No.: 353 1 202 2223
Email: info@lenoxsystems.com
Contact Person:
Mr. Paul O’ Rourke
Walker (Director)
Email: paul@lenoxsystems.com
N K ENGINEERS
(WORKS):
|
Address: |
Behind Arbuda
Mills, Near Navnit Prakashan Press, Sukhram Nagar, Ahmedabad – 380 021, Gujarat, India. |
|
Mobile No.: |
91-9825018492 |
|
Tel. No. (O): |
91-79-22745767/
22744761 |
|
Tel. No. (R): |
91-79-26308392 |
|
Fax No.: |
91-79-22744761 |
|
Email: |
|
|
Area: |
1200 sq. mts. |
Company Profile:
|
Business Type: |
Manufacturers |
|
Year of
Established: |
1966 |
|
Range of Products: |
All types of
Material Handling Equipments |
|
Line of Business: |
Manufacturer of Goods Lifts, Wire Ropes, Hoists, EOT/ HOT
Cranes, Chain Pulley Block. |
|
Production Type: |
Wholly-Owned |
|
No. of Staff: |
35 |
|
No. of Engineers: |
4 |
|
Investment
on Manufacturing Equipment |
Rs. 5.000 Millions
|
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.41.07 |
|
UK Pound |
1 |
Rs.81.69 |
|
Euro |
1 |
Rs.55.84 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
48 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|